Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Lancranjan · SciRah

Researcher profile · Semantic Scholar

I. Lancranjan

Share profile

I. Lancranjan — researcher profile on SciRah

h-index: 21
Works: 83
Citations: 2,690

Most-cited papers

Reproductive ability of workmen occupationally exposed to lead.
I. Lancranjan, H. I. Popescu, Olimpia Găvănescu, I. Klepsch +1 more
1975Archives of Environmental Health An International Journal473 citations
Semantic Scholar
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
A. Colao, D. Ferone, P. Marzullo, P. Cappabianca +4 more
2001Journal of Clinical Endocrinology and Metabolism287 citations Open access
Semantic Scholar
Sandostatin LAR in acromegalic patients: long-term treatment.
Anette Kvistborg Fløgstad, J. Halse, S. Bakke, I. Lancranjan +3 more
1997Journal of Clinical Endocrinology and Metabolism181 citations Open access
Semantic Scholar
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
Paul M. Stewart, K. Kane, Susan E. Stewart, I. Lancranjan +1 more
1995Journal of Clinical Endocrinology and Metabolism153 citations
Semantic Scholar
A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments.
M. Bigazzi, R. Ronga, I. Lancranjan, S. Ferraro +5 more
1979Journal of Clinical Endocrinology and Metabolism151 citations
Semantic Scholar
Results of a European Multicentre Study with Sandostatin® LAR® in Acromegalic Patients
I. Lancranjan, A. Atkinson
2004Pituitary142 citations
Semantic Scholar
Long‐term therapy with long‐acting octreotide (Sandostatin‐LAR®) for the management of acromegaly
P. Davies, Susan E. Stewart, I. Lancranjan, M. C. Sheppard +1 more
1998Clinical Endocrinology134 citations
Semantic Scholar
First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis.
U. Leibundgut, I. Lancranjan
1987The Lancet127 citations
Semantic Scholar
Parenteral depot-systems on the basis of biodegradable polyesters
T. Kissel, Z. Brich, S. Bantle, I. Lancranjan +2 more
1991108 citations
Semantic Scholar
Dopamine D2 receptor gene expression in human adenohypophysial adenomas
L. Ştefăneanu, K. Kovacs, É. Horváth, M. Buchfelder +2 more
2001Endocrine93 citations
Semantic Scholar
Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients
I. Lancranjan, C. Bruns, P. Grass, P. Jaquet +8 more
199586 citations
Semantic Scholar
Gonadic function in workmen with long-term exposure to microwaves.
I. Lancranjan, Madelaine Maicanescu, Emilia Rafaila, I. Klepsch +1 more
1975Health Physics73 citations
Semantic Scholar
New evidence for growth hormone modulation by the α-adrenergic system in man
I. Lancranjan, P. Marbach
197752 citations
Semantic Scholar
Effect of dopamine agonist medication on prolactin producing pituitary adenomas
K. Kovacs, L. Ştefăneanu, É. Horváth, R. Lloyd +3 more
1991Virchows Archiv50 citations
Semantic Scholar
Alterations of spermatic liquid in patients chronically poisoned by carbon disulphide.
I. Lancranjan
1972La Medicina del lavoro41 citations
Semantic Scholar
Sandostatin LAR in acromegalic patients
Anette Kvistborg Fløgstad, J. Halse, T. Haldorsen, I. Lancranjan +3 more
199533 citations
Semantic Scholar
EFFECT OF BROMOCRIPTIN ON THE ENDOCRINE SYSTEM AND FETAL DEVELOPMENT
E. Pozo, A. Darragh, I. Lancranjan, D. Ebeling +4 more
1977Clinical Endocrinology31 citations
Semantic Scholar
RAPID AND LONG‐LASTING SUPPRESSION OF PROLACTIN SECRETION AND SHRINKAGE OF PROLACTINOMAS AFTER INJECTION OF LONG‐ACTING REPEATABLE FORM OF BROMOCRIPTINE (PARLODEL LAR) *
G. Schettini, G. Lombardi, B. Merola, A. Colao +3 more
1990Clinical Endocrinology29 citations
Semantic Scholar
Changes of the gonadic function in chronic carbon disulphide poisoning.
I. Lancranjan, H. I. Popescu, I. Klepsch
1969La Medicina del lavoro28 citations
Semantic Scholar
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
Enrica Ciccarelli, C. Miola, S. Grottoli, T. Avataneo +2 more
1993Journal of Clinical Endocrinology and Metabolism24 citations
Semantic Scholar
PARENTERAL BROMOCRIPTINE IN THE TREATMENT OF HORMONALLY ACTIVE PITUITARY TUMOURS
G. Benker, B. Gieshoff, O. Freundlieb, R. Windeck +3 more
1986Clinical Endocrinology21 citations
Semantic Scholar
Hormonal mechanism of milk secretion in the newborn.
J. Hiba, E. Pozo, A. Genazzani, E. Pusterla +3 more
1977Journal of Clinical Endocrinology and Metabolism21 citations
Semantic Scholar
The α-Adrenoceptor Control of Adrenocorticotropin Secretion in Man
I. Lancranjan, E. Ohnhaus, J. Girard
197920 citations
Semantic Scholar
Spermatogenesis alterations during protracted irradiation in man.
H. I. Popescu, I. Lancranjan
1975Health Physics19 citations
Semantic Scholar
Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients
A. Kaal, J. Frystyk, C. Skjærbæk, S. Nielsen +6 more
199516 citations
Semantic Scholar
Mood elevation and pituitary stimulation after i.v. l-5-HTP in normal subjects: Evidence for a common serotoninergic mechanism.
Wolfgang Pühringer, A. Wirz-Justice, I. Lancranjan
1976Neuroscience Letters16 citations
Semantic Scholar
The value of electromyographic changes in the early diagnosis of carbon disulphide peripheral neuropathy.
P. Manu, R. Lilis, I. Lancranjan, S. Ionescu +1 more
1970La Medicina del lavoro16 citations
Semantic Scholar
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma
G. Hildebrandt, J. Zierski, P. Christophis, Albrecht Laun +3 more
2005Acta Neurochirurgica15 citations
Semantic Scholar
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
Albert Beckers, P. Pétrossians, R. Abs, P. Flandroy +4 more
1992Journal of Clinical Endocrinology and Metabolism14 citations
Semantic Scholar
Inhibition of Lactation with Depot‐Bromocriptine
I. Lancranjan, Rune Rolland, M. L'hermite
198613 citations Open access
Semantic Scholar
Vasopressin in Neuropsychiatric Disorders
J. Legros, I. Lancranjan
198413 citations
Semantic Scholar
The Neural Regulation of Prolactin Secretion
I. Lancranjan, H. Friesen
197813 citations
Semantic Scholar
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia
E. Ciccarelli, E. Ghigo, E. Mazza, M. Andreis +3 more
1987Journal of Endocrinological Investigation12 citations
Semantic Scholar
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia
B. Merola, A. Colao, E. Caruso, F. Sarnacchiaro +3 more
1992Journal of Endocrinological Investigation11 citations
Semantic Scholar
A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
T. Brue, I. Lancranjan, J. Louvet, D. Dewailly +2 more
1992Fertility and Sterility11 citations Open access
Semantic Scholar
Chronic treatment with parlodel LAR® of patients with prolactin-secreting tumours: different responsiveness of micro- and macroprolactinomas
Caterina Maraschini, M. Moro, A. Masala, P. Toja +6 more
199111 citations
Semantic Scholar
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia
E. Ciccarelli, S. Grottoli, C. Miola, T. Avataneo +2 more
1994Clinical Endocrinology10 citations
Semantic Scholar
Effects of selective sleep deprivation on sleep-linked prolactin and growth hormone secretion
U. Beck, D. Marquetand, E. Pozo, I. Lancranjan
1976European Archives of Psychiatry and Neurological Sciences10 citations
Semantic Scholar
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
A. Lengyel, Wania Mussio, P. Imamura, J. G. H. Vieira +1 more
1993Fertility and Sterility9 citations Open access
Semantic Scholar
Return of gonadotropic function in postpartum women during bromocriptine treatment.
J. Kremer, R. Rolland, P. V. D. van der Heijden, C. M. Thomas +1 more
1989Fertility and Sterility9 citations Open access
Semantic Scholar
[Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly].
A. Priou, G. Lévesque, C. Simonetta, I. Lancranjan +2 more
1995Annales d'Endocrinologie8 citations
Semantic Scholar
Control of prolactin‐secreting macroadenomas with parenteral, long‐acting bromocriptine in 30 patients treated for up to 3 years
R. Haase, C. Jaspers, H. Schulte, I. Lancranjan +4 more
1993Clinical Endocrinology8 citations
Semantic Scholar
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
B. Merola, A. Coho, E. Caruso, F. Samacchiaro +4 more
1991Gynecological Endocrinology8 citations
Semantic Scholar
Lactation inhibition by a single injection of a new depot‐bromocriptine
J. Kremer, R. Rolland, P. Heijden, L. Schellekens +2 more
1990British Journal of Obstetrics and Gynaecology7 citations
Semantic Scholar
New evidence for growth hormone modulation by the alpha-adrenergic system in man.
I. Lancranjan, P. Marbach
1977Metabolism: Clinical and Experimental7 citations
Semantic Scholar
The influence of the prolactin-inhibitor bromocriptin (CB 154) on human luteal function in vivo
K. Schulz, W. Geiger, E. Pozo, K. H. Lose +2 more
1976Archiv für Gynäkologie7 citations
Semantic Scholar
Study of the thyroid function in chronic carbon disulphide poisoning.
I. Lancranjan, M. Sukmansky, L. Stănucă, C. Antonescu +1 more
1972La Medicina del lavoro7 citations
Semantic Scholar
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
M. Moro, C. Maraschini, P. Toja, A. Masala +5 more
1991Hormone Research6 citations
Semantic Scholar
Single Dose Bromocriptine Microcapsules in Postpartum Lactation Inhibition
L. Svanberg, I. Lancranjan, Torbjörn Arvidsson, B. Andersch
1987Acta Obstetricia et Gynecologica Scandinavica6 citations
Semantic Scholar
Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
Rune Rolland, W. Nijdam, A. Weyer, I. Lancranjan
1986European Journal of Obstetrics, Gynecology, and Reproductive Biology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Marbach×7
Invite
P. Marbach — researcher profile on SciRah
H. I. Popescu×5
Invite
H. I. Popescu — researcher profile on SciRah
C. Bruns×4
Invite
C. Bruns — researcher profile on SciRah
E. Pozo×4
Invite
E. Pozo — researcher profile on SciRah

×3

Invite

I. Klepsch — researcher profile on SciRah

Invite

A. Colao — researcher profile on SciRah

Invite

G. Lombardi — researcher profile on SciRah

Invite

J. Jervell — researcher profile on SciRah

Invite

P. Jaquet — researcher profile on SciRah

G. Schettini×3

Invite

G. Schettini — researcher profile on SciRah

Invite

B. Merola — researcher profile on SciRah

Invite

E. Caruso — researcher profile on SciRah